![](static/images/product/product-icon-neural-antibodies.png)
NeuroMab™ Anti-EPHA2 BBB Shuttle Antibody, Clone NR267P
- Host Species:
- Humanized
- Species Reactivity:
- Human
- Applications:
- In Vitro; Inhib; Cyt
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
SPECIFIC INQUIRY
inquiryDescription
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.
Species Reactivity
Clonality
Host Species
Clone Number
Applications
Relevant Diseases
Storage
Research Use Only
Target
Official Name
Full Name
Alternative Names
Figure 1 Kinetic analysis of EphA2 phosphorylation in MDA-MB-231 cells. WT wild-type untreated cells; MW molecular weight marker; P-EphA2 phosphorylated Epha2
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-1.png)
Figure 2A Inhibition of EphA2 phosphorylation after EphrinA1/Fc induced NCI-H1299 cells (5A) and MDA-MB-231 cells (5B), respectively; WT wild-type untreated cells; MW molecular weight markers; P-EphA2 phosphorylation Normalized EphA2.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-2.png)
Figure 2B EphrinA1/Fc induced inhibition of EphA2 phosphorylation in NCI-H1299 cells (5A) and MDA-MB-231 cells (5B), respectively; WT wild-type untreated cells; MW molecular weight markers; P-EphA2 phosphorylation Normalized EphA2.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-3.png)
Figure 3 Cytotoxic activity of hu2H11R35R74-PEG4-Mal-DM4 compared to hu2H11-PEG4-Mal-DM4 (small filled circles DAR=6.7; large filled circles DAR=7.0).
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-4.png)
Figure 4 Time graph (semi-logarithmic scale) representing the mean plasma concentration of hu2H11-SPDB-DM4 following a single intravenous dose of 20 mg/kg immunoconjugate in HGS to male CD-1 mice (n=2 ). Total concentrations of human IgG (solid diamonds) and conjugated moieties (open squares) are shown.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-5.png)
Figure 5 Time plot (semi-logarithmic scale) representing mean plasma concentrations of hu2H11R35R74-PEG4-NHAc-DM4 (n=2) after single dose intravenous administration of 20 mg/kg immunoconjugate in HGS to male CD- 1 Mouse. Total concentrations of human IgG (solid diamonds) and conjugated moieties (open squares) are shown.
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-6.png)
Figure 6A Bar graph representation of PK parameters of hu2H11R35R74-PEG4-NHAc-DM4 under various DARs, exposure to (AUC(0-inf); Figure 9A) and clearance (Cl; Figure 9B) of several ADCs DAR function following a single intravenous dose of 20 mg/kg of HGS immunoconjugate to male CD-1 mice (n=4).
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-7.png)
Figure 6B PK parameters of hu2H11R35R74-PEG4-NHAc-DM4 in various DARs, exposed to (AUC(0-inf); Figure 9A) and cleared (Cl; Figure 9B) for several ADCs. DAR function after a single intravenous dose of 20 mg/kg of HGS immunoconjugate in male CD-1 mice (n=4).
![](https://img.creative-biolabs.com/neuros/productImages/NRZP-1022-ZP3855-8.png)
Publications (0)